Literature DB >> 25441299

Rate of asthma trial outcomes reporting on ClinicalTrials.gov and in the published literature.

Chris Stockmann1, Joseph S Ross2, Catherine M T Sherwin3, Christopher A Reilly4, Brittany McDowell3, Bernhard Fassl3, Flory Nkoy3, Christopher G Maloney3, Michael G Spigarelli5.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25441299      PMCID： PMC4261054          DOI： 10.1016/j.jaci.2014.09.019

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  7 in total

1.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

2.  Medicine. Moving toward transparency of clinical trials.

Authors:  Deborah A Zarin; Tony Tse
Journal:  Science       Date:  2008-03-07       Impact factor: 47.728

Review 3.  Reporting "basic results" in ClinicalTrials.gov.

Authors:  Tony Tse; Rebecca J Williams; Deborah A Zarin
Journal:  Chest       Date:  2009-07       Impact factor: 9.410

4.  Comparison of registered and published primary outcomes in randomized controlled trials.

Authors:  Sylvain Mathieu; Isabelle Boutron; David Moher; Douglas G Altman; Philippe Ravaud
Journal:  JAMA       Date:  2009-09-02       Impact factor: 56.272

5.  Data torturing.

Authors:  J L Mills
Journal:  N Engl J Med       Date:  1993-10-14       Impact factor: 91.245

6.  The ClinicalTrials.gov results database--update and key issues.

Authors:  Deborah A Zarin; Tony Tse; Rebecca J Williams; Robert M Califf; Nicholas C Ide
Journal:  N Engl J Med       Date:  2011-03-03       Impact factor: 91.245

7.  Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study.

Authors:  Andrew P Prayle; Matthew N Hurley; Alan R Smyth
Journal:  BMJ       Date:  2012-01-03
  7 in total
  2 in total

1.  Postmarket studies required by the US Food and Drug Administration for new drugs and biologics approved between 2009 and 2012: cross sectional analysis.

Authors:  Joshua D Wallach; Alexander C Egilman; Sanket S Dhruva; Margaret E McCarthy; Jennifer E Miller; Steven Woloshin; Lisa M Schwartz; Joseph S Ross
Journal:  BMJ       Date:  2018-05-24

2.  Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource.

Authors:  Ben Goldacre; Nicholas J DeVito; Carl Heneghan; Francis Irving; Seb Bacon; Jessica Fleminger; Helen Curtis
Journal:  BMJ       Date:  2018-09-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.